3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Dexamethasone
17
Melphalan
14
Bortezomib
10
Calcium Dobesilate
8
Filgrastim
6
Granulocyte Colony-Stimulating Factor
5
Cyclophosphamide
5
birtamimab
4
dexamethasone acetate
3
Whole-Body Irradiation
3
Thalidomide
3
Peripheral Blood Stem Cell Transplantation
3
Lenalidomide
3
fludarabine phosphate
2
daratumumab
2
Mycophenolic Acid
2
Etoposide
2
Doxycycline
2
Darbepoetin alfa
2
Cyclosporine
2
Busulfan
2
Blood Component Removal
2
pomalidomide
1
pegfilgrastim
1
ixazomib
1
isatuximab
1
ferrous sulfate
1
ferric gluconate
1
dexamethasone 21-phosphate
1
carfilzomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoglobulin Light-chain Amyloidosis
×
sargramostim
×
Clear all
No trials found.